Artemether Injection 40 mg / 80 mg contains the active substance Artemether which is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy. It is a semi-synthetic derivative of artemisinin extracted from the herb Artemisia annua.
Artemether Injection is effective in geographical regions where resistance to chloroquine has been reported. It is an alternative to injectable Artesunate (when it is not available) in the:
Each ml contains:
Artemether 40/80mg
Injections
Malaria
Artemether Injection is indicated for the treatment of iron deficiency in the following indications:
Artemether Injection is used to replenish body iron stores in dialysis-dependent and non-dialysis-dependent chronic kidney disease (NDD-CKD) patients. Iron deficiency may be caused by blood loss during dialysis, increased erythropoiesis secondary to erythropoietin use, and insufficient absorption of iron from the gastrointestinal tract. Iron is essential to the synthesis of hemoglobin to maintain oxygen transport and to the function and formation of the physiologically important heme and non-heme compounds. Most dialysis patients require intravenous iron to maintain sufficient iron stores.
Drug interactions have not been studied. However, Iron sucrose may reduce the absorption of concomitantly administered oral iron preparations.
Allergic reactions, Low blood pressure, Nausea, Constipation, Headache, Insomnia (difficulty in sleeping), Constipation, Pain at the site of injection